Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease

[1]  Jeremy Ferlic,et al.  WGCNA : Weighted Gene Co-Expression Network Analysis , 2016 .

[2]  D. Zhi,et al.  Screening genes crucial for pediatric pilocytic astrocytoma using weighted gene coexpression network analysis combined with methylation data analysis , 2014, Cancer Gene Therapy.

[3]  Hai Zhang,et al.  GenCLiP 2.0: a web server for functional clustering of genes and construction of molecular networks based on free terms , 2014, Bioinform..

[4]  Duan Ma,et al.  Integrated microRNA–mRNA analysis of coronary artery disease , 2014, Molecular Biology Reports.

[5]  Jonathan E. Clark,et al.  Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer , 2013, BMC Systems Biology.

[6]  Peter McGuffin,et al.  Integrative mouse and human mRNA studies using WGCNA nominates novel candidate genes involved in the pathogenesis of major depressive disorder. , 2013, Pharmacogenomics.

[7]  J. Hata,et al.  Epidemiology of stroke and coronary artery disease in Asia. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[8]  John Barnard,et al.  Weighted Gene Coexpression Network Analysis of Human Left Atrial Tissue Identifies Gene Modules Associated With Atrial Fibrillation , 2013, Circulation. Cardiovascular genetics.

[9]  Tetsuya Ohira,et al.  Cardiovascular disease epidemiology in Asia: an overview. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[10]  Xia Yang,et al.  A Systems Biology Framework Identifies Molecular Underpinnings of Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[11]  I. Benjamin,et al.  Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. , 2013, Antioxidants & redox signaling.

[12]  F. Recchia,et al.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. , 2013, American journal of physiology. Heart and circulatory physiology.

[13]  T. Vijayakumar,et al.  Molecular Studies on Coronary Artery Disease—A Review , 2013, Indian Journal of Clinical Biochemistry.

[14]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[15]  Satoshi Okayama,et al.  Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography , 2013, Heart and Vessels.

[16]  Jennifer G. Robinson,et al.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis , 2012, The Lancet.

[17]  K. Bornfeldt,et al.  S100A8 and S100A9 in cardiovascular biology and disease. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[18]  K. Kario,et al.  S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[19]  Olli Saarela,et al.  A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease , 2011, Circulation. Cardiovascular genetics.

[20]  Andre R. O. Cavalcanti,et al.  Multiple Independent Fusions of Glucose-6-Phosphate Dehydrogenase with Enzymes in the Pentose Phosphate Pathway , 2011, PloS one.

[21]  T. Lincoln,et al.  Mechanism of glucose-6-phosphate dehydrogenase-mediated regulation of coronary artery contractility. , 2011, American journal of physiology. Heart and circulatory physiology.

[22]  H. Bøtker,et al.  A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[23]  Thomas M. Aune,et al.  Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes. , 2011, Genes and immunity.

[24]  Weixiong Zhang,et al.  A general co-expression network-based approach to gene expression analysis: comparison and applications , 2010, BMC Systems Biology.

[25]  Chunquan Li,et al.  SubpathwayMiner: a software package for flexible identification of pathways , 2009, Nucleic acids research.

[26]  Guoping Fan,et al.  Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells , 2009, BMC Genomics.

[27]  G. Ertl,et al.  Post-infarct remodelling: contribution of wound healing and inflammation , 2008, Cardiovascular research.

[28]  David Osumi-Sutherland,et al.  FlyBase: enhancing Drosophila Gene Ontology annotations , 2008, Nucleic Acids Res..

[29]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[30]  Jun Dong,et al.  Geometric Interpretation of Gene Coexpression Network Analysis , 2008, PLoS Comput. Biol..

[31]  S. Muntoni,et al.  Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease , 2008, Journal of Inherited Metabolic Disease.

[32]  David Bryant,et al.  DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..

[33]  Kathleen C. Lee,et al.  S100A7 (Psoriasin)--mechanism of antibacterial action in wounds. , 2007, The Journal of investigative dermatology.

[34]  Dennis B. Troup,et al.  NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..

[35]  Andy M. Yip,et al.  Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.

[36]  E. Sarandöl,et al.  Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. , 2006, Clinical biochemistry.

[37]  D. Gutterman,et al.  Hypoxia, coronary dilation, and the pentose phosphate pathway. , 2006, American journal of physiology. Heart and circulatory physiology.

[38]  J. Loscalzo,et al.  Glucose-6 Phosphate Dehydrogenase Deficiency Decreases the Vascular Response to Angiotensin II , 2005, Circulation.

[39]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[40]  Z. Ungvari,et al.  Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. , 2003, American journal of physiology. Heart and circulatory physiology.

[41]  A. Tajik,et al.  Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease , 2003, Circulation.

[42]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[43]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[44]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[45]  R. Narang,et al.  Interrelationship between lipid peroxidation, ascorbic acid and superoxide dismutase in coronary artery disease , 2002 .

[46]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[47]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[48]  F. Sebening,et al.  [Coronary artery disease]. , 1980, Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung.